LifeVantage (LFVN) Set to Announce Quarterly Earnings on Wednesday

LifeVantage (NASDAQ:LFVN) will issue its quarterly earnings data after the market closes on Wednesday, February 7th.

LifeVantage (NASDAQ:LFVN) last issued its earnings results on Wednesday, November 8th. The company reported $0.07 earnings per share (EPS) for the quarter. LifeVantage had a net margin of 0.64% and a return on equity of 24.24%.

Shares of LifeVantage (NASDAQ LFVN) opened at $4.55 on Wednesday. The stock has a market cap of $68.89, a price-to-earnings ratio of 50.56 and a beta of 0.57. LifeVantage has a 52 week low of $2.86 and a 52 week high of $7.54. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.84 and a current ratio of 1.54.

LifeVantage announced that its Board of Directors has initiated a share repurchase plan on Monday, November 27th that authorizes the company to buyback $5.00 million in shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: “LifeVantage (LFVN) Set to Announce Quarterly Earnings on Wednesday” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at

LifeVantage Company Profile

LifeVantage Corporation is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy lifestyle and financial freedom.

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with's FREE daily email newsletter.

Leave a Reply